摘要
目的分析小儿支原体肺炎患儿采用孟鲁司特钠联合阿奇霉素治疗的临床效果。方法该次研究方便选取的88例患儿入选时间为2019年1月—2020年1月,均确诊为小儿支原体肺炎,分组采用随机数字法的方式,将44例采用阿奇霉素治疗的患儿作为对照组,另外44例采用孟鲁司特钠与阿奇霉素联合治疗的作为联合组,对联合组与对照组患儿的临床治疗效果进行比较。结果与对照组总有效率84.1%相比,联合组患儿的治疗有效率(95.5%)更高,差异有统计学意义(P<0.05);联合组患儿发热消失、喘息及咳嗽消失、肺部体征消失及X线肺部炎症消失时间分别为(4.3±1.7)、(4.9±2.3)、(4.6±2.1)、(1.4±5.0)d;对照组为(5.4±2.2)、(8.1±3.2)、(6.7±1.8)、(2.2±5.0)d,联合组短于对照组,差异有统计学意义(P<0.05)。结论孟鲁司特钠联合阿奇霉素治疗的效果更为显著,可将其作为首选治疗方案临床推广。
Objective To analyze the clinical effect of montelukast sodium combined with azithromycin in children with mycoplasma pneumonia.Methods Convenient select the 88 children in this study were enrolled from January 2019 to January 2020,and all were diagnosed with mycoplasma pneumonia in children.The random number method was used for grouping,and 44 children treated with azithromycin were used as the control group.The other 44 cases were treated with montelukast sodium and azithromycin as the combined group,and the clinical treatment effects of the combined group and the control group were compared.Results Compared with the total effective rate of 84.1%in the control group,the effective rate of treatment for children in the combined group(95.5%)was higher,and the difference was statistically significant(P<0.05);the time of disappearance of fever,wheezing and coughing,disappearance of lung signs,and disappearance of X-ray pulmonary inflammation in children in the combined group were(4.3±1.7)d,(4.9±2.3)d,(4.6±2.1)d,(1.4±5.0)d;the control group was(5.4±2.2)d,(8.1±3.2)d,(6.7±1.8)d,(2.2±5.0)d,the combination group was shorter than the control group,the difference was statistically significant(P<0.05).Conclusion The effect of montelukast sodium combined with azithromycin is more significant,and it can be used as the first choice for clinical promotion.
作者
徐青
汤文银
XU Qing;TANG Wenyin(Department of Pediatrics,Gaoyou People's Hospital,Gaoyou,Jiangsu Province,225600 China)
出处
《中外医疗》
2021年第11期111-113,共3页
China & Foreign Medical Treatment
关键词
小儿支原体肺炎
孟鲁司特钠
阿奇霉素
临床效果
Mycoplasma pneumonia in children
Montelukast sodium
Azithromycin
Clinical effect
